Vitiligo News and Research

RSS
Vitiligo is a pigmentation disorder in which melanocytes (the cells that make pigment) in the skin are destroyed. As a result, white patches appear on the skin in different parts of the body. Similar patches also appear on both the mucous membranes (tissues that line the inside of the mouth and nose) and the retina (inner layer of the eyeball). The hair that grows on areas affected by vitiligo sometimes turns white.
Study opens way for targeted local treatments for patchy skin disorders

Study opens way for targeted local treatments for patchy skin disorders

Contact dermatitis or contact eczema?

Contact dermatitis or contact eczema?

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

Study provides new insights into development of skin-depigmenting disease vitiligo

Study provides new insights into development of skin-depigmenting disease vitiligo

New research on EdnrB, Wnt signaling pathways could lead to therapies for skin pigment disorders

New research on EdnrB, Wnt signaling pathways could lead to therapies for skin pigment disorders

Researchers successfully treat eczema patients using rheumatoid arthritis drug

Researchers successfully treat eczema patients using rheumatoid arthritis drug

UT Southwestern dermatologist improves technique to treat skin discoloration from vitiligo

UT Southwestern dermatologist improves technique to treat skin discoloration from vitiligo

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

Penn study has implications for developing new cell-based treatments for skin disease

Penn study has implications for developing new cell-based treatments for skin disease

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

PhotoMedex third quarter 2013 revenues decrease 19% to $45.9 million

PhotoMedex third quarter 2013 revenues decrease 19% to $45.9 million

PhotoMedex introduces NEOVA's hyper-active moisturizer, DNA Barrier Accelerator

PhotoMedex introduces NEOVA's hyper-active moisturizer, DNA Barrier Accelerator

New proteins help patients to get more accurate diagnosis of MS

New proteins help patients to get more accurate diagnosis of MS

Research suggests loss of skin or hair color can be corrected by a new compound, pseudocatalase

Research suggests loss of skin or hair color can be corrected by a new compound, pseudocatalase

Mutant HSP70i protein may offer potent treatment opportunities for vitiligo

Mutant HSP70i protein may offer potent treatment opportunities for vitiligo

Vitiligo patients have low risk for skin cancer

Vitiligo patients have low risk for skin cancer

Wellness Center USA closes PSI acquisition

Wellness Center USA closes PSI acquisition